Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029812913> ?p ?o ?g. }
- W2029812913 endingPage "1583" @default.
- W2029812913 startingPage "1572" @default.
- W2029812913 abstract "Chronic treatment with opioid drugs such as morphine leads to the development of tolerance, which manifests as a loss of drug potency. The mechanisms underlying this phenomenon are poorly understood, but recent evidence suggests that increased activity of nociceptive sensory transmitters [calcitonin gene-related peptide (CGRP) and substance P] and other signalling messengers (prostaglandins) contribute to its development. Chronic intrathecal morphine administration to rats for 7 days produced analgesic tolerance. Co-administration of SR140333, a selective substance P receptor (neurokinin-1) antagonist, or nimesulide, a cyclooxygenase-2-selective inhibitor, augmented the acute effects of morphine, prevented morphine tolerance and reversed established tolerance. In cultured adult dorsal root ganglion neurons, exposure to morphine for 5 days increased the number of neurons expressing CGRP immunoreactivity. Co-exposure with the peptide CGRP receptor antagonist CGRP8-37, SR140333 or nimesulide prevented the morphine-induced increase in the expression of CGRP immunoreactivity. Additionally, BIBN4096BS, a nonpeptide CGRP receptor antagonist, stereoselectively produced similar effects. In summary, this investigation demonstrates that activity of CGRP and substance P contributes to both the induction and expression of opioid analgesic tolerance. Additionally, it highlights the involvement of prostaglandins generated by spinal cyclooxygenase-2 activity in the genesis of opioid tolerance. The neuropeptide and prostanoid activity contributing to tolerance is expressed at the level of the primary afferents terminating in the spinal cord. The combination of opioids with agents that block this activity may represent a useful strategy for the prevention as well as the reversal of clinical opioid tolerance." @default.
- W2029812913 created "2016-06-24" @default.
- W2029812913 creator A5016606343 @default.
- W2029812913 creator A5055183128 @default.
- W2029812913 creator A5055939807 @default.
- W2029812913 date "2003-09-01" @default.
- W2029812913 modified "2023-10-10" @default.
- W2029812913 title "Inhibition of neurokinin‐1–substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance <i>in vivo</i> and the morphine‐induced increase in CGRP expression in cultured dorsal root ganglion neurons" @default.
- W2029812913 cites W1552826266 @default.
- W2029812913 cites W1625856702 @default.
- W2029812913 cites W1626809853 @default.
- W2029812913 cites W1797399099 @default.
- W2029812913 cites W1824081845 @default.
- W2029812913 cites W185602361 @default.
- W2029812913 cites W1967345078 @default.
- W2029812913 cites W1967493826 @default.
- W2029812913 cites W1968515315 @default.
- W2029812913 cites W1978378330 @default.
- W2029812913 cites W1984741182 @default.
- W2029812913 cites W1985708326 @default.
- W2029812913 cites W1987964734 @default.
- W2029812913 cites W1989555351 @default.
- W2029812913 cites W1993881834 @default.
- W2029812913 cites W1997044455 @default.
- W2029812913 cites W1997179101 @default.
- W2029812913 cites W1997272422 @default.
- W2029812913 cites W2003546418 @default.
- W2029812913 cites W2007659283 @default.
- W2029812913 cites W2007936034 @default.
- W2029812913 cites W2010150274 @default.
- W2029812913 cites W2014435395 @default.
- W2029812913 cites W2015592781 @default.
- W2029812913 cites W2019370793 @default.
- W2029812913 cites W2028833035 @default.
- W2029812913 cites W2037175122 @default.
- W2029812913 cites W2040725197 @default.
- W2029812913 cites W2042253951 @default.
- W2029812913 cites W2047470848 @default.
- W2029812913 cites W2052840755 @default.
- W2029812913 cites W2062714491 @default.
- W2029812913 cites W2070487383 @default.
- W2029812913 cites W2073557461 @default.
- W2029812913 cites W2084545120 @default.
- W2029812913 cites W2084874301 @default.
- W2029812913 cites W2087994192 @default.
- W2029812913 cites W2107260256 @default.
- W2029812913 cites W2108111134 @default.
- W2029812913 cites W2110009002 @default.
- W2029812913 cites W2110636497 @default.
- W2029812913 cites W2121761530 @default.
- W2029812913 cites W2141778251 @default.
- W2029812913 cites W2143046795 @default.
- W2029812913 cites W2147107991 @default.
- W2029812913 cites W2148733966 @default.
- W2029812913 cites W2414686393 @default.
- W2029812913 doi "https://doi.org/10.1046/j.1460-9568.2003.02887.x" @default.
- W2029812913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14511336" @default.
- W2029812913 hasPublicationYear "2003" @default.
- W2029812913 type Work @default.
- W2029812913 sameAs 2029812913 @default.
- W2029812913 citedByCount "86" @default.
- W2029812913 countsByYear W20298129132012 @default.
- W2029812913 countsByYear W20298129132013 @default.
- W2029812913 countsByYear W20298129132014 @default.
- W2029812913 countsByYear W20298129132015 @default.
- W2029812913 countsByYear W20298129132016 @default.
- W2029812913 countsByYear W20298129132018 @default.
- W2029812913 countsByYear W20298129132019 @default.
- W2029812913 countsByYear W20298129132020 @default.
- W2029812913 countsByYear W20298129132022 @default.
- W2029812913 crossrefType "journal-article" @default.
- W2029812913 hasAuthorship W2029812913A5016606343 @default.
- W2029812913 hasAuthorship W2029812913A5055183128 @default.
- W2029812913 hasAuthorship W2029812913A5055939807 @default.
- W2029812913 hasConcept C118303440 @default.
- W2029812913 hasConcept C126322002 @default.
- W2029812913 hasConcept C134018914 @default.
- W2029812913 hasConcept C163170386 @default.
- W2029812913 hasConcept C170493617 @default.
- W2029812913 hasConcept C185592680 @default.
- W2029812913 hasConcept C2776533618 @default.
- W2029812913 hasConcept C2776885963 @default.
- W2029812913 hasConcept C2777389121 @default.
- W2029812913 hasConcept C2777570176 @default.
- W2029812913 hasConcept C2778122271 @default.
- W2029812913 hasConcept C2779886867 @default.
- W2029812913 hasConcept C2779985140 @default.
- W2029812913 hasConcept C2780820201 @default.
- W2029812913 hasConcept C2781063702 @default.
- W2029812913 hasConcept C71924100 @default.
- W2029812913 hasConcept C98274493 @default.
- W2029812913 hasConceptScore W2029812913C118303440 @default.
- W2029812913 hasConceptScore W2029812913C126322002 @default.
- W2029812913 hasConceptScore W2029812913C134018914 @default.
- W2029812913 hasConceptScore W2029812913C163170386 @default.
- W2029812913 hasConceptScore W2029812913C170493617 @default.
- W2029812913 hasConceptScore W2029812913C185592680 @default.
- W2029812913 hasConceptScore W2029812913C2776533618 @default.